Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:22 pm Purchase | 2026-06-30 | 13G | FAETH THERAPEUTICS INC FTH | Caligan Partners LP | 629,467 2.400% | 503,465 (+399.57%) | Filing History |
| 2026-08-14 4:15 pm Purchase | 2026-06-30 | 13G | FAETH THERAPEUTICS INC FTH | Trails Edge Capital Partners, LP | 515,335 2.000% | 389,325 (+308.96%) | Filing History |
| 2026-08-14 4:15 pm Purchase | 2026-06-15 | 13G | FAETH THERAPEUTICS INC FTH | Khosla Ventures VI, LP | 2,632,232 10.200% | 2,632,232 (New Position) | Filing History |
| 2026-08-14 12:00 pm Sale | 2026-06-30 | 13G | FAETH THERAPEUTICS INC FTH | StemPoint Capital LP | 0 0.000% | -132,873 (Position Closed) | Filing History |
| 2026-06-23 4:35 pm Purchase | 2026-06-15 | 13G | FAETH THERAPEUTICS INC FTH | Montanova Capital, LLC | 2,020,103 7.800% | 2,020,103 (New Position) | Filing History |
| 2026-06-23 4:01 pm Purchase | 2026-06-15 | 13G | FAETH THERAPEUTICS INC FTH | S2G Investments, LLC | 2,575,401 9.990% | 2,575,401 (New Position) | Filing History |
| 2026-06-03 4:52 pm Sale | 2026-06-01 | 13G | FAETH THERAPEUTICS INC FTH | Millennium Management LLC | 41,561 3.100% | -87,200 (-67.72%) | Filing History |
| 2026-05-15 4:04 pm Purchase | 2026-02-24 | 13G | FAETH THERAPEUTICS INC FTH | Millennium Management LLC | 128,761 9.600% | 128,761 (New Position) | Filing History |
| 2026-05-15 10:00 am Purchase | 2026-03-31 | 13G | FAETH THERAPEUTICS INC FTH | StemPoint Capital LP | 132,873 9.900% | 132,873 (New Position) | Filing History |
| 2026-05-15 08:32 am Purchase | 2026-03-31 | 13G | FAETH THERAPEUTICS INC FTH | Caligan Partners LP | 126,002 9.400% | 126,002 (New Position) | Filing History |
| 2026-02-25 4:15 pm Purchase | 2026-02-18 | 13G | FAETH THERAPEUTICS INC FTH | Trails Edge Capital Partners, LP | 126,010 9.900% | 126,010 (New Position) | Filing History |
| 2024-03-07 6:00 pm Sale | 2024-03-05 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Newtyn Management, LLC | 62,112 4.950% | -10,722 (-14.72%) | Filing History |
| 2024-02-13 5:34 pm Sale | 2024-02-09 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Newtyn Management, LLC | 72,834 5.830% | -13,874 (-16.00%) | Filing History |
| 2023-11-03 5:03 pm Purchase | 2023-10-25 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Newtyn Management, LLC | 86,708 6.500% | 86,708 (New Position) | Filing History |
| 2023-08-04 4:41 pm Sale | 2023-07-31 | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Cambrian BioPharma Inc | 182,656 14.600% | -79,142 (-30.23%) | Filing History |
| 2023-06-02 5:00 pm Sale | 2023-06-01 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 0 0.000% | -172,083 (Position Closed) | Filing History |
| 2023-05-23 4:50 pm Unchanged | 2023-05-23 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 172,083 11.100% | 0 (Unchanged) | Filing History |
| 2023-03-09 5:15 pm Purchase | 2023-03-09 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 172,083 11.200% | 110 (+0.06%) | Filing History |
| 2023-02-14 11:36 am Purchase | 2022-12-31 | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Cambrian BioPharma Inc | 261,798 17.000% | 224 (+0.09%) | Filing History |
| 2022-11-21 06:15 am Unchanged | 2022-11-21 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 171,973 11.200% | 0 (Unchanged) | Filing History |